RSSCategory: Pharmaceuticals

Australia develops world’s first AI-flu vaccine

July 17, 2019

A new influenza vaccine has been developed in South Australia by an artificial intelligence (AI) program, after a spate of confirmed cases in the country. The first accomplishment of its kind sees the flu drug being independently created by SAM – Search Algorithm for Ligands – a computer program used by a research team at […]

Continue Reading

“Unsuitable” antidepressant drugs pose problem to older adults

July 10, 2019

Older adults are easily susceptible to major depressive disorder. Data points to some 15-20% of people aged 65 and above, who live independently, deal with serious symptoms, and those in nursing homes face depression rates of up to 50%. However, researchers caution against the harmful effects of antidepressants for treating major depressive disorder in older […]

Continue Reading

Scientists tease brain aneurysm treatment with cancer drug

May 24, 2019

There may be a way to treat sensitive brain aneurysms, traditionally only addressed through delicate surgery and slim success, with an existing drug. The joint effort by scientists from UK’s University of Sussex and US’s University of Washington School of Medicine involves a receptor tyrosine kinase (TK) inhibitor – a class of drug currently used […]

Continue Reading

UK to develop new treatments for cancer drug resistance

May 17, 2019

UK’s Institute of Cancer (ICR) recent £75million investment on a centre to develop drugs against treatment-resistant cancer could idealise a breakthrough within the next decade. The ICR’s new Centre for Drug Discovery at its south London campus is intended to bring together almost 300 scientists from different disciplines to overcome/redirect cancer evolution. Chief Executive Professor […]

Continue Reading

China HIV drug to control disease transmission

May 16, 2019

HIV remains a global health concern despite numerous treatment methods, but a new drug promises better outcomes over a similar treatment used for the past decade. Chinese researchers at the Shanghai Institute of Materia Medica and the Kunming Institute of Zoology of the Chinese Academy of Sciences in Yunnan, China, have developed a safe CCR5 […]

Continue Reading

WHO launches pilot malaria vaccine in Malawi

April 25, 2019

Recent figures report a marked rise of deadly malaria cases after nearly a decade of fighting the disease – mostly in Africa, where more than 250,000 children die yearly; the WHO records a total of 435,000 malaria deaths worldwide in 2017. Numerous campaigns advocate for effective malaria treatment, thus, in a landmark immunisation project, according […]

Continue Reading

Biotech companies to help with cancer research

March 18, 2019

Biotechnological innovations are the latest addition to the healthcare market with new therapies and drugs to treat cancer more effectively at a reduced cost, although the most common therapies remain immunotherapy, chemotherapy, and radiation therapy. Cancer is the leading cause of death globally – Allied Market Research data from 2017-2023 has estimated the global cancer […]

Continue Reading

New TB vaccine tested on mice shows promise

March 11, 2019

Tuberculosis is a disease caused by the Mycobacterium tuberculosis (Mtb) bacteria, and is the world’s leading killer due to infection according to the WHO. The BCG (bacille-Calmette-Guerin) vaccine – delivered by an intramuscular injection in the upper arm – is made to use against Mtb infections; some 70-80% effective against more severe forms such as […]

Continue Reading

Jamaica receives medical support from India in new agreement

February 22, 2019

India’s pharmaceutical capabilities are reaching new heights – the country is likely to be amongst the highest ranking global markets in value terms by 2020. Indian High Commissioner to Jamaica, His Excellency Sevala Naik said that India has been recognised globally for producing quality medicines at affordable prices. In line with this, a memorandum of […]

Continue Reading

New leukemia drug is more effective and easier to use

January 14, 2019

A landmark study co-authored by a Loyola Medicine oncologist has found that a newer targeted drug is significantly more effective than standard therapy for treating elderly patients with chronic lymphocytic leukemia (CLL). The drug, ibrutinib, attacks cancer cells without damaging normal cells, thus causing fewer side effects. The drug is taken as a pill once […]

Continue Reading